
    
      Each study age group/arm will be divided into two groups of treatment. One group will receive
      investigational product and one other group will receive active comparator. This Study is
      sequential age de-escalation. To be conducted in heathy adults (18-40 years old) and followed
      by children (10-17 years old) ). Before the study started, the subjects will be assessed for
      anti HBs Antibody. For subjects with anti-HBs not protective (< 10mIU/mL) before
      immunization, additional 2 doses will be required with 1 month interval.
    
  